Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer

16 Jan 2018

Abstract excerpt

// Amanda B. Pilling 1,2 , Jihye Kim 1 , Adriana Estrada-Bernal 1 , Qiong Zhou 1 , Anh T. Le 1 , Katherine R. Singleton 1 , Lynn E. Heasley 1 , Aik Choon Tan 1 , James DeGregori 1 and Robert C. Doebele 1 1 University of Colorado Cancer Center, Aurora, CO, USA 2 Henry Ford Cancer Institute, Detroit, MI, USA Correspondence to: Robert C. Doebele, email: // Keywords : ALK; ROS1; NSCLC; MYC; synthetic lethality...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29507657
DOI: 10.18632/oncotarget.24260

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancerPMID 29507657Read ↗

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.Semantic proximity Read ↗

ALK in lung cancer: past, present, and future.Semantic proximity Read ↗

A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.Semantic proximity Read ↗

ALK alterations and inhibition in lung cancer.Semantic proximity Read ↗

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.Semantic proximity Read ↗

ALK gene alterations in cancer: biological aspects and therapeutic implications.Semantic proximity Read ↗

Inhibition of ALK Signaling for Cancer TherapySemantic proximity Read ↗

Targeting oncogenic ALK: a promising strategy for cancer treatment.Semantic proximity Read ↗

Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine.Semantic proximity Read ↗

Treatment for ALK-mutated non-small-cell lung cancer: a new miracle in the research race.Semantic proximity Read ↗

Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer.Semantic proximity Read ↗

Unraveling the Potential of ALK-Targeted Therapies in NSCLC: Comprehensive Insights and Future DirectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.